a genetic lean model of type 2 diabetes originating from
selective breeding over many generations of glucose-intolerant
nondiabetic Wistar rats. Regarding type 1 diabetes
models, the NOD mouse typically presents hyperglycemia
between 12 and 30 weeks of age, whereas in BB rats it occurs
around 12 weeks of age. One great advantage of these models
is that they can also be employed as model of atherosclerosis
which represents the long-term complication of diabetes
mellitus and tested against several natural products [70, 76,
78, 80–82].